store at low temperature
store at -20°C
Talquetamab (JNJ-64407564) is a T-cell retargeting GPRC5D bispecific antibody for multiple myeloma with antitumor activity that induces T-cell-mediated killing of GPRC5-expressing MM cells through T-cell recruitment and activation.Talquetamab is used to treat multiple myeloma (MM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 289.00 | |
2 mg | In stock | $ 437.00 | |
5 mg | In stock | $ 723.00 | |
10 mg | In stock | $ 1,160.00 | |
25 mg | In stock | $ 1,720.00 | |
50 mg | In stock | $ 2,320.00 | |
100 mg | In stock | $ 3,130.00 |
Description | Talquetamab (JNJ-64407564) is a T-cell retargeting GPRC5D bispecific antibody for multiple myeloma with antitumor activity that induces T-cell-mediated killing of GPRC5-expressing MM cells through T-cell recruitment and activation.Talquetamab is used to treat multiple myeloma (MM). |
In vitro | Talquetamab, at concentrations ranging from 0.00128 to 4.0 μg/mL for 48 hours, effectively induces lysis of multiple myeloma cells. This induction is accompanied by a significant dose-dependent increase in the proportion of activated CD4+ and CD8+ T cells, as well as elevated levels of granule enzyme B and inflammatory cytokines such as IL-6, IL-8, and TNF-α [2]. |
In vivo | Talquetamab (JNJ-64407564), administered subcutaneously or intravenously at doses ranging from 0.1 to 50 µg, exhibits significant anti-tumor activity in H929 and MM mouse models [1]. |
Synonyms | JNJ-64407564, JNJ-7564 |
Molecular Weight | N/A |
CAS No. | 2226212-40-2 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Talquetamab 2226212-40-2 GPCR/G Protein Neuroscience Dopamine Receptor JNJ-64407564 JNJ-7564 inhibitor inhibit